EUR 75.75
(-3.13%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.95 Billion EUR | -6.15% |
2022 | 2.08 Billion EUR | 11.18% |
2021 | 1.87 Billion EUR | 9.22% |
2020 | 1.71 Billion EUR | 1.01% |
2019 | 1.69 Billion EUR | -7.67% |
2018 | 1.84 Billion EUR | 11.25% |
2017 | 1.65 Billion EUR | 2.71% |
2016 | 1.61 Billion EUR | -6.44% |
2015 | 1.72 Billion EUR | 63.74% |
2014 | 1.05 Billion EUR | -0.08% |
2013 | 1.05 Billion EUR | 7.65% |
2012 | 977.59 Million EUR | 1.53% |
2011 | 962.84 Million EUR | 16.23% |
2010 | 828.42 Million EUR | -3.71% |
2009 | 860.36 Million EUR | -18.77% |
2008 | 1.05 Billion EUR | 13.04% |
2007 | 936.96 Million EUR | 0.0% |
2006 | - EUR | -100.0% |
2005 | 5.9 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 2 Billion EUR | 2.57% |
2024 Q2 | 2.04 Billion EUR | 1.65% |
2024 Q3 | 2.1 Billion EUR | 3.18% |
2023 Q3 | 1.9 Billion EUR | 3.54% |
2023 FY | 1.95 Billion EUR | -6.15% |
2023 Q1 | 2.07 Billion EUR | -0.31% |
2023 Q2 | 1.83 Billion EUR | -11.53% |
2023 Q4 | 1.95 Billion EUR | 2.77% |
2022 Q3 | 2.22 Billion EUR | 10.32% |
2022 Q4 | 2.08 Billion EUR | -6.24% |
2022 FY | 2.08 Billion EUR | 11.18% |
2022 Q1 | 1.89 Billion EUR | 1.21% |
2022 Q2 | 2.01 Billion EUR | 6.2% |
2021 Q1 | 1.7 Billion EUR | -0.58% |
2021 Q3 | 1.8 Billion EUR | 4.4% |
2021 FY | 1.87 Billion EUR | 9.22% |
2021 Q4 | 1.87 Billion EUR | 3.91% |
2021 Q2 | 1.72 Billion EUR | 1.27% |
2020 FY | 1.71 Billion EUR | 1.01% |
2020 Q1 | 1.71 Billion EUR | 0.61% |
2020 Q4 | 1.71 Billion EUR | 0.28% |
2020 Q3 | 1.71 Billion EUR | 0.5% |
2020 Q2 | 1.7 Billion EUR | -0.38% |
2019 Q3 | 1.71 Billion EUR | 1.59% |
2019 Q1 | 1.69 Billion EUR | -7.89% |
2019 FY | 1.69 Billion EUR | -7.67% |
2019 Q2 | 1.69 Billion EUR | -0.3% |
2019 Q4 | 1.69 Billion EUR | -1.03% |
2018 Q2 | 1.42 Billion EUR | -9.13% |
2018 FY | 1.84 Billion EUR | 11.25% |
2018 Q4 | 1.84 Billion EUR | 0.78% |
2018 Q3 | 1.82 Billion EUR | 28.47% |
2018 Q1 | 1.56 Billion EUR | -5.44% |
2017 Q1 | 1.58 Billion EUR | -1.69% |
2017 FY | 1.65 Billion EUR | 2.71% |
2017 Q4 | 1.65 Billion EUR | 9.92% |
2017 Q3 | 1.5 Billion EUR | -2.08% |
2017 Q2 | 1.53 Billion EUR | -2.94% |
2016 FY | 1.61 Billion EUR | -6.44% |
2016 Q3 | 1.67 Billion EUR | 0.14% |
2016 Q2 | 1.67 Billion EUR | 0.05% |
2016 Q1 | 1.67 Billion EUR | -2.96% |
2016 Q4 | 1.61 Billion EUR | -3.75% |
2015 Q3 | 1.05 Billion EUR | -2.73% |
2015 Q4 | 1.72 Billion EUR | 63.05% |
2015 Q2 | 1.08 Billion EUR | 1.25% |
2015 Q1 | 1.07 Billion EUR | 1.96% |
2015 FY | 1.72 Billion EUR | 63.74% |
2014 Q4 | 1.05 Billion EUR | 0.63% |
2014 Q3 | 1.04 Billion EUR | -1.6% |
2014 Q2 | 1.06 Billion EUR | 2.9% |
2014 Q1 | 1.03 Billion EUR | -1.92% |
2014 FY | 1.05 Billion EUR | -0.08% |
2013 Q4 | 1.05 Billion EUR | -2.63% |
2013 Q3 | 1.08 Billion EUR | -4.32% |
2013 Q2 | 1.12 Billion EUR | 6.89% |
2013 Q1 | 1.05 Billion EUR | 8.11% |
2013 FY | 1.05 Billion EUR | 7.65% |
2012 Q2 | 983.42 Million EUR | 4.44% |
2012 FY | 977.59 Million EUR | 1.53% |
2012 Q4 | 977.59 Million EUR | 0.46% |
2012 Q3 | 973.13 Million EUR | -1.05% |
2012 Q1 | 941.58 Million EUR | -2.21% |
2011 FY | 962.84 Million EUR | 16.23% |
2011 Q3 | 918.77 Million EUR | -1.78% |
2011 Q2 | 935.39 Million EUR | 17.19% |
2011 Q4 | 962.84 Million EUR | 4.8% |
2011 Q1 | 798.18 Million EUR | -3.65% |
2010 FY | 828.42 Million EUR | -3.71% |
2010 Q4 | 828.42 Million EUR | -1.7% |
2010 Q3 | 842.72 Million EUR | -3.97% |
2010 Q2 | 877.6 Million EUR | 1.95% |
2010 Q1 | 860.81 Million EUR | 0.05% |
2009 FY | 860.36 Million EUR | -18.77% |
2009 Q4 | 860.36 Million EUR | 0.0% |
2008 FY | 1.05 Billion EUR | 13.04% |
2007 FY | 936.96 Million EUR | 0.0% |
2006 FY | - EUR | -100.0% |
2005 FY | 5.9 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
SCHOTT Pharma AG & Co. KGaA | 539.64 Million EUR | -262.601% |
Carl Zeiss Meditec AG | 860.02 Million EUR | -127.526% |
Fielmann Aktiengesellschaft | 1.2 Billion EUR | -61.773% |
Sartorius Aktiengesellschaft | 6.99 Billion EUR | 72.038% |
Sartorius Aktiengesellschaft | 6.99 Billion EUR | 72.038% |